Cargando…

WS07.06 CFTR impacts SARS-CoV-2 infection in cystic fibrosis

Detalles Bibliográficos
Autores principales:	Bragonzi, A., Capurro, V., Cigana, C., Galietta, L.J., Gianferro, F., Pagani, I., Pedemonte, N., Venturini, A., Vicenzi, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. Published by Elsevier B.V. 2023
Materias:	Workshops
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250887/ http://dx.doi.org/10.1016/S1569-1993(23)00228-X

Ejemplares similares

WS11.2 The psychological implications and health risks of cystic fibrosis preand post-CFTR modulator therapy
por: Keyte, R., et al.
Publicado: (2021)

WS14.3 Virtual consultation in cystic fibrosis: an Italian experience
por: Carnovale, V., et al.
Publicado: (2021)

WS14.1 The effect of the COVID-19 pandemic on quality of life of adults with cystic fibrosis
por: Birkin, E., et al.
Publicado: (2021)

Mutual Effects of Single and Combined CFTR Modulators and Bacterial Infection in Cystic Fibrosis
por: Cigana, Cristina, et al.
Publicado: (2023)

WS14.4 Exploring cystic fibrosis patient and staff perceptions of the Virtual Healthcare Hub during the COVID-19 pandemic at the All Wales Adult Cystic Fibrosis Service
por: Birkin, E., et al.
Publicado: (2021)

Comprehensive Analysis of Combinatorial Pharmacological Treatments to Correct Nonsense Mutations in the CFTR Gene
por: Venturini, Arianna, et al.
Publicado: (2021)

WS14.5 SARS-CoV-2 driving rapid change in cystic fibrosis services: the role of the clinical nurse specialist
por: Dunk, R., et al.
Publicado: (2021)

Pharmacological Correctors of Mutant CFTR Mistrafficking
por: Pedemonte, Nicoletta, et al.
Publicado: (2012)

WS11.4 Randomised controlled trial piloting the “Coping and Learning to Manage Stress in CF” (CALM) telehealth intervention to reduce depressive and anxious symptoms in adults with cystic fibrosis
por: Bathgate, C., et al.
Publicado: (2021)

The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs
por: Sondo, Elvira, et al.
Publicado: (2022)

CFTR Rescue by Lumacaftor (VX-809) Induces an Extensive Reorganization of Mitochondria in the Cystic Fibrosis Bronchial Epithelium
por: Braccia, Clarissa, et al.
Publicado: (2022)

High-Throughput Screening for Modulators of CFTR Activity Based on Genetically Engineered Cystic Fibrosis Disease-Specific iPSCs
por: Merkert, Sylvia, et al.
Publicado: (2019)

Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells
por: Scudieri, Paolo, et al.
Publicado: (2020)

WS20.06 Co-infection with Nocardia farcinia and SARS-CoV-2 causing the death of an adolescent with cystic fibrosis
por: Chapman, J., et al.
Publicado: (2022)

Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment
por: Capurro, Valeria, et al.
Publicado: (2021)

Cystic Fibrosis, CFTR, and Colorectal Cancer
por: Scott, Patricia, et al.
Publicado: (2020)

Cystic Fibrosis-Niche Adaptation of Pseudomonas aeruginosa Reduces Virulence in Multiple Infection Hosts
por: Lorè, Nicola Ivan, et al.
Publicado: (2012)

WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic
por: Richards, K., et al.
Publicado: (2021)

Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations
por: Pedemonte, Nicoletta, et al.
Publicado: (2011)

CFTR and Ca(2+) Signaling in Cystic Fibrosis
por: Antigny, Fabrice, et al.
Publicado: (2011)

Strategies to circumvent the CFTR defect in cystic fibrosis
por: Becq, Frédéric, et al.
Publicado: (2013)

Not All Is CFTR – Neutrophils and Cholesterol in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2017)

Cystic Fibrosis and Oxidative Stress: The Role of CFTR
por: Moliteo, Evelina, et al.
Publicado: (2022)

CFTR modulators: transformative therapies for cystic fibrosis
por: Dwight, Mary, et al.
Publicado: (2021)

Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia
por: Veit, Guido, et al.
Publicado: (2012)

A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators
por: Ponzano, Stefano, et al.
Publicado: (2018)

CERN Bulletin Issue No. 06-07/2015
Publicado: (2015)

CERN Bulletin Issue No. 06-07/2012
Publicado: (2012)

CERN Bulletin Issue No. 06-07/2023
Publicado: (2023)

CERN Bulletin Issue No. 06-07/2013
Publicado: (2013)

CERN Bulletin Issue No. 06-07/2014
Publicado: (2014)

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999)

Fixing cystic fibrosis by correcting CFTR domain assembly
por: Okiyoneda, Tsukasa, et al.
Publicado: (2012)

Targeted therapies to improve CFTR function in cystic fibrosis
por: Brodlie, Malcolm, et al.
Publicado: (2015)

Lived experiences of individuals with cystic fibrosis on CFTR-modulators
por: Page, Annelise, et al.
Publicado: (2022)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

Nutritional impact of CFTR modulators in children with cystic fibrosis
por: Gaschignard, Margaux, et al.
Publicado: (2023)

Cross‐talk between CFTR and sphingolipids in cystic fibrosis
por: Dobi, Dorina, et al.
Publicado: (2023)

Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators
por: Terlizzi, Vito, et al.
Publicado: (2023)

Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis Airways Influences Virulence of Staphylococcus aureus In Vitro and Murine Models of Co-Infection
por: Baldan, Rossella, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gavaplacui3ekk99g567s7evp4